Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: A comparison between sustained virological responders and non-responders

Liver International

Volumn 30, Issue 4, 2010, Pages 567-573

  Carneiro, Valdirene Leão ^a   Lemaire, Denise C ^a,b,c   Bendicho, Maria Teresita ^a,b   Souza, Sabrina L ^a   Cavalcante, Lourianne Nascimento ^a   Angelo, Ana Luisa ^a   Freire, Songeli Menezes ^a,b   Mendes, Carlos Maurício Cardeal ^a   Santana, Nelma ^a   Lyra, Luiz G Costa ^a   Lyra, André Castro ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^c UNIVERSIDADE DO ESTADO DA BAHIA   (Brazil)

Author keywords

Antiviral therapy; Chronic hepatitis C; HLA C; Interferon; KIR; Natural killer cells

Indexed keywords

ALCOHOL; ALPHA INTERFERON; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; NATURAL KILLER CELL RECEPTOR; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; ETHNICITY; FEMALE; GENDER; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HUMAN; IMMUNOMODULATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; VIRUS ENTRY;

ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENE FREQUENCY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HLA-C ANTIGENS; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; RECEPTORS, KIR2DL5; RECEPTORS, NATURAL KILLER CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; STATISTICS, NONPARAMETRIC; TREATMENT FAILURE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 77950607813     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02212.x     Document Type: Article

References (25)

1. Orange JS, Fassett MS, Koopman LA, Boyson JE, Strominger Jl. Viral evasion of natural killer cells. Nat Immunol 2002, 3:1006-12.
2. Ljunggren Hg, Karre K. In search of the missing self: MHC molecules and NK recognition. Immunol Today 1991, 11:237-44.
3. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002, 20:217-51.
4. Martin AM, Freitas EM, Witt CS, Christiansen FT. The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 2000, 51:268-80.
5. Hsu CK, Chida S, Geraghty DE, Dupont B. The Killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002, 190:40-52.
6. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel Patterns of HLA-C allotype recognition. J Immunol 1998, 161:571-7.
7. Moretta A, Vitale M, Bottino C. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I moléculas in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993, 178:597-604.
8. Middleton D, Curran M, Maxwell L. Natural killer cells and their receptors. Transpl Immunol 2002, 10:147-64.
9. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002, 36:35-46.
10. Mchutchinson JG, Gordon SC, Schiff ER. Interferon Alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998, 339:1458-92.
11. Dustin LB, Rice CM. Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol 2007, 25:71-99.
12. Sastre AG, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 2006, 312:879-82.
13. Malaponte G, Passero E, Leonardi S. Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C. Acta Haematol 1997, 98:83-8.
14. Yamaji K, Nabeshima S, Murata M. Interferon-α/β upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocelular carcinoma cell lines and in chronic hepatitis C patients during interferon-α/β. Cancer Immunol Immunother 2006, 55:394-403.
15. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Natural killer cell-mediated control of infections requires production of interleukin 15 by type I IFN-triggered dendritic cells. Immunity 2007, 26:503-17.
16. Khakoo SI, Thio Cl, Martin MP. HLA and NK cell inhibitory receptor genes in resolving hepatitis C vírus infection. Science 2004, 305:872-74.
17. Montes-Cano MA, Caro-Oleas Jl, Romero-Gómez M. HLA-C and KIR genes in hepatitis C vírus infection. Hum Immunol 2005, 66:1106-9.
18. López-Vázquez A, Rodrigo L, Martinez-Borra J. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C vírus infection. J Infect Dis 2005, 192:162-5.
19. Kawarabavashi N, Seki S, Hatsuse K. Decrease of CD56+ T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000, 32:962-9.
20. Brodsky FM, Lem L, Solache A, Bennett EM. Human pathogen subversion of antigen presentation. Immunol Rev 1999, 168:199-215.
21. Estefanía E, Flores R, Gómez-Lozano N. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 2007, 178:4402-10.
22. Paladino N, Flores AC, Marcos CY. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007, 69:109-11.
23. Zúñiga J, Romero V, Azocar J. Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol Immunol 2009, 46:2723-7.
24. Khakoo SI, Carrington M. KIR and disease: a model system or system of models. Immunol Rev 2006, 214:186-201.
25. Freeman AJ, Dore GJ, Law MG. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001, 34:809-16.